TrialMedicina (Kaunas, Lithuania)2022

Ameliorative Potential of L-Alanyl L-Glutamine Dipeptide in Colon Cancer Patients Receiving Modified FOLFOX-6 Regarding the Incidence of Diarrhea, the Treatment Response, and Patients' Survival: A Randomized Controlled Trial.

Nesreen M Sabry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.